Science, Discovery, Tech and Environment · 13 November 2026

IIT-Kanpur study reveals macrophage pathway that rapidly suppresses insulin secretion

Exam-focused facts from the 13 November 2026 current affairs briefing.

Key facts

  • Researchers at the Indian Institute of Technology-Kanpur (IIT-Kanpur) identified a molecular pathway by which pancreatic immune cells called macrophages can suppress insulin release from beta cells within minutes, with findings published in the Journal of Clinical Investigation.
  • The process involves sphingolipids, a class of fats released by macrophages, rather than the inflammatory proteins traditionally linked to obesity-related pancreatic damage.
  • The trigger is GPR18, a receptor on macrophages; when activated it prompts release of sphingolipids, which beta cells take up through a surface transporter, interfering with their insulin-producing machinery.
  • In mouse models, activating the pathway reduced insulin secretion, while switching it off or blocking GPR18 restored insulin release.
  • Working with the Indiana Biosciences Research Institute in the US, the team confirmed the same pathway is present and active in human pancreatic tissue, where activation also suppressed insulin secretion.
  • The study was led by co-first authors Simran Singh and Ashish Kumar under the supervision of Sai Prasad Pydi, assistant professor in IIT-Kanpur's department of biological sciences and bioengineering.
  • The findings establish a potential drug target to preserve insulin production in people with obesity and Type-2 diabetes, though not an immediate treatment.